ATS Medical (ATSI) Posts Q3 Loss of 1c, In-Line with Estimates
ATS Medical (NASDAQ: ATSI) reports Q3 loss of $0.01, even with the analyst estimate of ($0.01). Revenue for the quarter was $18.80 million, which compares to the estimate of $18.65 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Signet Jewelers (SIG) Tops Q1 EPS by 5c; Guides Q2 Below the Street
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
